A Study of Zanzalintinib in People With Meningioma

Full Title

A Phase 2, Single-Arm, Multicenter, Open-Label Study of Zanzalintinib in Participants with Recurrent of Progressive Meningioma

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Thomas Kaley’s office at 212-639-5122.

Protocol
26-180
Phase
Phase II (phase 2)
Disease Status
Relapsed or Refractory
Investigator
Thomas J. Kaley
Co-Investigators
Christian Grommes
Diseases
Brain Tumors, Primary
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT07428616
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description